erythrasma: a skin disease that causes brown, scaly skin patches. It is caused by the Gram-positive bacterium Corynebacterium minutissimum. It is prevalent among diabetics and the obese, and in warm climates; it is worsened by wearing occlusive clothing.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
77 |
4. Check minimum number of eventsNone |
77 |
5. Include endpointsNone |
77 |
6. Filter based on genotype QC (FinnGen only) |
77 |
Control definitions (FinnGen only)
- Control exclude
- L12_INFECT_SKIN
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- L08
- Name in latin
- Erythrasma
Similar endpoints
↥List of similar endpoints to
Erythrasma
based on the number of shared cases.
Similar with more cases:
- Other local infections of skin and subcutaneous tissue
- Infections of the skin and subcutaneous tissue
- Diseases of the skin and subcutaneous tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 476 | 191 | 281 |
| Only index persons | 408 | 160 | 248 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 50.66 | 50.13 | 50.99 |
| Only index persons | 47.94 | 47.52 | 48.22 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 77 | 27 | 50 |
| Unadjusted period prevalence (%) | 0.02 | 0.01 | 0.02 |
| Median age at first event (years) | 52.13 | 53.47 | 51.40 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 70
- Matched controls
- 708
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L08.1
ICD-10 Finland
Erythrasma
+∞
81.9
62
*
L30.9
ICD-10 Finland
Dermatitis, unspecified
5.8
8.9
28
71
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
10.3
8.7
17
21
3900A
ICD-9 Finland
Rheumatic fever without mention of heart involvement[FEBRIS RHEUMATICA, MORBO CORDIS NON INDICATO]
+∞
7.4
7
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768443) Skin Pathology biopsy report
11
22
5.68
5.45
1.1
1.1
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
43
244
2.76
4.49
7.3
5.8
%
0.7
0.7
0.08
43
232
(3006504) Eosinophils/100 leukocytes in Blood
44
254
2.74
4.42
7.8
5.8
%
2.8
2.8
0.02
44
241
(3019069) Monocytes/100 leukocytes in Blood
44
257
2.69
4.28
8.5
6.1
%
9.0
8.6
0.46
44
245
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
41
232
2.67
4.24
10.5
6.3
mmol/l
1.2
1.2
0.63
35
202
(3001604) Monocytes [#/volume] in Blood
46
276
2.69
4.22
7.4
5.7
e9/l
0.6
0.6
0.71
41
242
(3013650) Neutrophils [#/volume] in Blood by Automated count
49
309
2.65
3.98
11.6
8.3
e9/l
3.8
4.1
0.43
44
275
(3007853) Bacteria identified in Skin by Aerobe culture
17
62
3.24
3.90
1.3
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
8
9.48
3.86
1.1
1.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
8
9.48
3.86
1.1
1.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
33
177
2.53
3.70
5.3
6.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
26
126
2.62
3.57
4.1
3.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
26
135
2.41
3.04
5.1
2.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
20
93
2.56
2.93
1.1
1.3
u/ml
1.9
15.3
—
6
38
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
32
185
2.26
2.91
5.7
2.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
32
189
2.20
2.73
1.9
1.8
pmol/l
96.8
89.6
0.36
22
110
(3012544) pH of Venous blood
12
44
3.05
2.69
4.9
4.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
14
58
2.73
2.54
1.6
1.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
22
114
2.31
2.54
1.2
2.0
mg/l
1.2
1.2
0.07
14
99
(3037467) Urinalysis macro (dipstick) panel - Urine
50
359
2.15
2.52
6.0
3.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
20
101
2.33
2.44
1.6
1.4
g/l
3.7
2.5
0.97
13
64
(3018418) pH of Serum or Plasma
25
140
2.17
2.39
7.2
3.2
ph
7.4
7.4
—
5
22
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
31
189
2.08
2.38
2.9
3.3
ng/l
28.1
82.3
1.12
22
127
(40760892) CBC W Ordered Manual Differential panel - Blood
23
126
2.18
2.31
7.7
4.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
21
112
2.21
2.25
1.5
1.3
u/ml
2.3
1.4
—
5
30
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
13
57
2.54
2.11
1.5
1.7
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
14
64
2.46
2.10
4.6
2.1
g/l
2.5
2.3
0.35
14
59
(3000991) Gas panel - Venous blood
10
39
2.80
2.01
7.4
4.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
8
27
3.19
2.00
1.6
1.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
18
96
2.15
1.91
1.1
1.4
iu/ml
41.6
47.6
—
5
33
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
19
104
2.10
1.89
1.5
1.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
16
82
2.20
1.86
1.6
1.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
31
206
1.85
1.77
11.9
8.8
inr
1.1
1.2
—
8
48
(3017143) Hepatitis C virus Ab [Presence] in Serum
16
85
2.12
1.71
1.6
1.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
14
71
2.19
1.67
1.1
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
22
133
1.92
1.66
5.0
6.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
7
27
2.75
1.55
2.6
2.3
u/l
43.3
39.4
—
7
21
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
5
15
3.49
1.55
1.8
1.9
g/l
0.2
0.3
—
5
15
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
6
21
3.01
1.54
1.3
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
25
162
1.81
1.52
2.1
2.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
14
74
2.09
1.51
4.7
2.2
umol/l
13.5
16.0
0.44
14
66
(3026008) Bacteria identified in Urine by Culture
19
113
1.91
1.49
4.8
2.8
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
5
16
3.27
1.46
2.4
2.3
ug/min
48.8
132.3
—
5
10
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
23
2.74
1.39
1.2
1.0
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
6
23
2.74
1.39
10.3
5.2
mmol/l
25.4
24.9
—
6
23
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
5
17
3.07
1.38
1.8
1.8
g/l
1.1
1.2
—
5
17
(3002385) Erythrocyte distribution width [Ratio]
57
475
1.80
1.38
23.2
14.4
%
13.8
13.7
0.24
57
462
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
15
85
1.95
1.35
5.0
2.0
e6/l
0.6
0.7
—
9
47
(1761482) Bacteria [#/volume] in Urine by Culture
5
19
2.74
1.23
6.6
5.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
23
154
1.71
1.23
6.8
4.0
mg/mmol
19.9
8.9
0.33
15
103
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
14
80
1.92
1.23
5.1
2.1
e6/l
0.4
2.3
—
8
43
(3000330) Specific gravity of Urine by Test strip
6
26
2.42
1.21
6.7
4.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
19
121
1.76
1.20
1.6
2.0
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
5
21
2.47
1.11
1.2
1.1
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
7
33
2.23
1.09
4.4
4.6
g/l
124.7
130.8
—
7
33
(3012516) Albumin [Mass/volume] in Urine
21
142
1.66
1.07
4.6
3.4
mg/l
171.8
65.4
0.34
12
99
(3015736) pH of Urine
28
205
1.58
1.05
4.9
2.9
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
29
217
1.54
0.98
2.0
2.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
31
237
1.52
0.94
12.2
7.9
e9/l
0.0
0.0
0.00
25
186
(3021879) Hepatitis B virus core Ab [Presence] in Serum
10
56
1.90
0.93
1.4
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
0
24
0.00
0.81
0.0
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
46
391
1.45
0.78
4.2
3.6
pmol/l
14.4
14.5
0.15
41
362
(3019832) Treponema pallidum Ab [Presence] in Serum
9
55
1.72
0.77
1.9
1.8
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
5
25
2.07
0.74
3.6
2.8
%
0.7
0.8
—
5
25
(36660697) Celiac disease serology panel - Serum
7
41
1.78
0.72
1.3
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
5
26
1.99
0.72
11.2
3.6
%
50.0
49.3
—
5
26
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
5
26
1.99
0.72
3.6
2.7
%
1.6
1.6
—
5
26
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
26
1.99
0.72
1.2
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
5
26
1.99
0.72
1.0
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
7
42
1.73
0.70
5.0
2.4
e9/l
3.6
4.1
—
7
33
(3035350) Ketones [Presence] in Urine by Test strip
33
268
1.41
0.70
5.4
3.0
estimate
0.0
0.0
—
8
46
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
5
27
1.91
0.70
8.2
7.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
21
157
1.47
0.69
5.4
2.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
33
269
1.40
0.69
7.2
4.4
estimate
0.0
0.0
—
9
45
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
16
113
1.53
0.68
1.3
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
17
122
1.51
0.67
1.9
2.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
12
79
1.62
0.67
1.4
1.3
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
5
28
1.84
0.67
8.8
4.5
mmol/l
23.7
24.2
—
5
28
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
28
1.84
0.67
2.2
1.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
29
233
1.40
0.65
4.9
3.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
12
80
1.59
0.64
1.9
1.7
—
—
—
0
0
(3044889) 12 lead EKG panel
44
380
1.38
0.63
3.7
3.6
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
8
52
1.60
0.62
7.1
6.4
%
94.8
96.4
—
8
47
(3009261) Glucose [Presence] in Urine by Test strip
33
273
1.37
0.62
5.4
3.1
estimate
0.0
0.0
—
9
42
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
8
53
1.57
0.61
1.8
1.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
6
36
1.72
0.58
1.8
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
6
38
1.63
0.56
8.3
2.9
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
9
63
1.49
0.55
2.1
2.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
8
59
1.40
0.42
1.6
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
5
33
1.55
0.42
1.4
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
0
17
0.00
0.41
0.0
4.5
—
193.5
—
0
17
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
0
19
0.00
0.39
0.0
4.2
—
84.9
—
0
19
(3019225) pH of Specimen
6
44
1.39
0.35
4.2
4.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
25
216
1.23
0.31
5.2
3.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
53
495
1.23
0.30
5.8
4.2
mu/l
2.0
1.8
0.45
47
460
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
24
207
1.23
0.30
3.3
3.9
%
21.4
20.3
—
9
98
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
8
66
1.24
0.28
1.1
1.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
61
582
1.24
0.25
22.4
13.0
mmol/l
139.9
139.7
0.26
61
568
(3003694) ABO and Rh group [Type] in Blood
18
153
1.23
0.25
1.3
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
5
37
1.38
0.24
2.8
4.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
5
38
1.34
0.24
3.6
5.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
11
0.00
0.21
0.0
3.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
11
0.00
0.21
0.0
3.8
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
4.2
—
2.5
—
0
12
(3003181) Sodium [Moles/volume] in Urine
0
12
0.00
0.21
0.0
1.5
—
78.3
—
0
12
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
60
575
1.21
0.21
20.9
12.1
mg/l
21.1
23.4
0.27
51
441
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
47
1.30
0.21
1.5
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(4094501)
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
7
59
1.21
0.18
1.6
1.2
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
64
624
1.16
0.12
23.9
13.5
umol/l
88.3
80.1
0.67
64
624
(1761868) Lipid panel - Serum or Plasma
24
223
1.11
0.11
5.0
2.6
—
—
—
0
0
(3013512) EKG study
17
156
1.12
0.09
5.6
3.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
6
56
1.08
0.09
11.2
6.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
58
594
0.90
0.08
5.9
4.5
mmol/l
2.8
2.8
0.14
53
555
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
56
546
1.10
0.08
16.9
10.3
ml/min/173m2
81.2
85.0
0.44
43
438
(3035941) MCH [Entitic mass]
66
654
1.07
0.01
30.6
17.3
pg
30.3
30.4
0.16
66
647
(40761511) CBC panel - Blood by Automated count
62
618
1.02
0.00
19.3
11.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
15
148
1.02
0.00
3.1
2.7
ug/l
0.4
0.7
—
10
104
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
40
405
0.97
0.00
2.6
3.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
55
555
0.97
0.00
6.2
4.3
mmol/l
6.2
5.9
0.72
49
516
(3024731) MCV [Entitic volume]
66
655
1.06
0.00
30.7
17.3
fl
90.6
90.8
0.10
66
648
(3000963) Hemoglobin [Mass/volume] in Blood
66
655
1.06
0.00
30.7
17.4
g/l
138.3
140.5
0.57
66
649
(3026361) Erythrocytes [#/volume] in Blood
66
655
1.06
0.00
30.7
17.3
e12/l
4.6
4.6
0.27
66
638
(3029937) Albumin [Presence] in Urine by Test strip
14
139
1.01
0.00
5.1
3.2
estimate
0.0
0.0
—
9
43
(3011397) Hemoglobin [Presence] in Urine by Test strip
12
119
1.01
0.00
4.8
3.0
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
0
7
0.00
0.00
0.0
1.1
—
13.5
—
0
7
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
5.1
—
23.4
—
0
7
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
7
70
1.00
0.00
2.1
2.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
8
0.00
0.00
0.0
1.4
—
12.8
—
0
8
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
55
550
1.00
0.00
20.5
12.1
%
41.1
41.0
0.04
37
440
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
6
63
0.95
0.00
1.7
2.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4035726)
5
56
0.89
0.00
1.4
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
0.8
—
0
8
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
68.7
—
0
9
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
21.6
—
0
6
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3000492) Spirometry study
6
64
0.93
0.00
1.3
1.3
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
5.4
—
0
5
(3016038) Potassium [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
29.8
—
0
6
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6
62
0.97
0.00
1.2
1.5
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
0
6
0.00
0.00
0.0
1.2
—
1.6
—
0
6
(3035320) C reactive protein [Mass/volume] in Body fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint L12_ERYTHRASMA and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have L12_ERYTHRASMA.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: L12_ERYTHRASMA – Erythrasma
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data